Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Regulus Therapeutics Inc. (RGLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 Collier Kathryn J (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 Witz Pascale (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 Rosen Hugh (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 RASTETTER WILLIAM H (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 Klassen Preston (President & Head of R & D) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 225,000 options to buy @ $1.36, valued at $306k
08/14/2023 4 Huang Alice Shih-hou (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 CALSADA CRISPINA (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 375,000 options to buy @ $1.36, valued at $510k
08/14/2023 4 Hagan Joseph P (President and CEO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 1,312,500 options to buy @ $1.36, valued at $1.8M
08/14/2023 4 BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $1.36, valued at $20.4k
08/14/2023 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 393,750 options to buy @ $1.36, valued at $535.5k
06/12/2023 4 Klassen Preston (President & Head of R & D) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 350,000 options to buy @ $1.46, valued at $511k
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Collier Kathryn J (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 90,000 options to buy @ $0.27, valued at $24.3k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Rosen Hugh (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 90,000 options to buy @ $0.27, valued at $24.3k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Witz Pascale (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 90,000 options to buy @ $0.27, valued at $24.3k
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2022 4 CALSADA CRISPINA (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $1.31, valued at $65.5k
05/11/2022 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 70,000 options to buy @ $1.31, valued at $91.7k
03/01/2022 4 Drygin Denis (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Bought 76,686 shares @ $0.23, valued at $17.6k
02/07/2022 4 Drygin Denis (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Bought 23,314 shares @ $0.23, valued at $5.4k
01/26/2022 4 Drygin Denis (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 400,000 options to buy @ $0.26, valued at $104k
01/26/2022 4 Hagan Joseph P (President and CEO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Bought 100,000 shares @ $0.2152, valued at $21.5k
Granted 1,600,000 options to buy @ $0.26, valued at $416k
01/26/2022 4 CALSADA CRISPINA (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 480,000 options to buy @ $0.26, valued at $124.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy